News for '-biotechs'

Sterling Biotech to buy Rallis' gelatine biz

Sterling Biotech to buy Rallis' gelatine biz

Rediff.com22 Jan 2004

Rallis India Ltd, a Tata group company, is to sell its gelatine business to Sterling Biotech Ltd for Rs 47 crore in an all cash deal.

Pharma co mired in syrup deaths shuts production at Noida unit

Pharma co mired in syrup deaths shuts production at Noida unit

Rediff.com30 Dec 2022

The move has come days after the state government announced to form a special investigation team to probe into the death of Disha Salian, the former manager of late actor Sushant Singh Rajput.

Uzbek syrup deaths: India begins probe, manufacturing halted

Uzbek syrup deaths: India begins probe, manufacturing halted

Rediff.com29 Dec 2022

Samples of the cough syrup have been taken from the manufacturing premises in Noida and sent to the Regional Drugs Testing Laboratory (RDTL) in Chandigarh for testing, Mandaviya said.

India's biotech sector crosses $1 bn mark

India's biotech sector crosses $1 bn mark

Rediff.com10 Jun 2005

India's biotechnology industry has crossed the $1 billion mark in revenues.

Biotech firms invest $400 mn in Karnataka

Biotech firms invest $400 mn in Karnataka

Rediff.com20 Apr 2005

Karnataka has attracted 18 new biotechnology firms and a total investment of $400 million (Rs 1,800 crore), including Rs 750 crore (Rs 7.5 billion) from India's biggest biotech firm Biocon, in the last 12 months.

US keen to partner India in biotech

US keen to partner India in biotech

Rediff.com26 Jun 2003

India's biotech industry has a vast potential for bilateral cooperation with US firms for collaborative research, technology trade, licensing and distribution.\n\n\n\n

Biocon in top 25 global biotech cos' list

Biocon in top 25 global biotech cos' list

Rediff.com17 Jul 2008

Indian biotech firm Biocon has been featured amongst the top 25 global biotehnology companies according to a report released by Med Ad News.

2 Indian vaccine makers sitting on stockpile of 250mn Covid doses

2 Indian vaccine makers sitting on stockpile of 250mn Covid doses

Rediff.com28 Dec 2022

According to respective company sources, Biological E is holding 200 million doses of its COVID-19 vaccine Corbevax while Bharat Biotech is sitting on a stockpile of 50 million doses of Covaxin.

Matrix to buy 55% stake in Concord Biotech

Matrix to buy 55% stake in Concord Biotech

Rediff.com6 Dec 2005

Matrix said the acquisition of a controlling stake of 55% was aimed at adding to its technology and manufacturing strengths and to utilise the market potential of the fermentation technology-based products of Concord.

Biotech sector eyes $4,500 mn by '10

Biotech sector eyes $4,500 mn by '10

Rediff.com1 Dec 2005

Fuelled by growing markets and a liberalised economy, the Indian biotech industry is set to witness an exponential growth with an estimated turnover of $4,500 million by 2010.

'None of the fresh biotech grads are employment-ready'

'None of the fresh biotech grads are employment-ready'

Rediff.com10 Mar 2010

In an interview with Nandita Datta she talks about biotechnology becoming the new buzzword and what it takes to build a successful career.

After Gambia, Uzbekistan links deaths of 18 kids to Indian syrup

After Gambia, Uzbekistan links deaths of 18 kids to Indian syrup

Rediff.com29 Dec 2022

According to the ministry, chemical ethylene glycol was found in a batch of syrup during laboratory tests.

Biotech cos wake up to India's genetic jackpot

Biotech cos wake up to India's genetic jackpot

Rediff.com13 Jun 2005

Indian scientists as well as biotech firms have awakened to the fact that there is a genetic jackpot in the country's endogamous gene pool.

Does India have enough vaccine reserves to combat another Covid wave?

Does India have enough vaccine reserves to combat another Covid wave?

Rediff.com27 Dec 2023

According to CoWIN data, only 73 vaccination centres are currently active in India, of which 32 are government-run.

Under the lens: Regulator moots pre-export govt testing for cough syrup cos

Under the lens: Regulator moots pre-export govt testing for cough syrup cos

Rediff.com24 May 2023

After reports of contamination in cough syrups sent from the country, India is considering a system to test them before exporting. It is learnt that the Central Drugs Standard Control Organisation (CDSCO) has sent a proposal to the Union health ministry on this. The idea is to test the medicines at government labs before exporting.

'NIKKI=CORRUPT': Ramaswamy steps up attack against Haley

'NIKKI=CORRUPT': Ramaswamy steps up attack against Haley

Rediff.com7 Dec 2023

Ramaswamy launched the volley of charges against the former South Carolina governor and US ambassador to the UN in Arizona during the Republican Party's fourth presidential debate, which was attended by just four candidates, the other two being former New Jersey Governor Chris Christie and Florida Governor Ron DeSantis.

DuPont opens 1st biotech arm outside US

DuPont opens 1st biotech arm outside US

Rediff.com14 Mar 2007

US-based science products and services firm DuPont announced on Wednesday start of its first plant biotech research centre outside US in Hyderabad.

Covid: Parl panel stresses swift strategy evolution for next-gen vaccines

Covid: Parl panel stresses swift strategy evolution for next-gen vaccines

Rediff.com20 Dec 2023

The ICMR-National Institute of Virology has been regularly undertaking studies to understand the protective efficacy of COVID-19 vaccines against emerging variants.

Trump triumphs in Iowa caucuses, heads for Biden rematch

Trump triumphs in Iowa caucuses, heads for Biden rematch

Rediff.com16 Jan 2024

Trump's victory in his first election since his unusual exit in 2020 has also laid to rest any lingering questions about his hold over the GOP and the potency of his right-wing message.

'APIs are a very strategic part of Biocon's business'

'APIs are a very strategic part of Biocon's business'

Rediff.com7 Jan 2024

'There is no reason why we should break this business up.'

Indian biotech exports up 47% to $1.2bn

Indian biotech exports up 47% to $1.2bn

Rediff.com14 Jun 2007

Exports revenue of Indian biotech industry grew by 47 per cent during 2006-07 at Rs 4,937 crore (USD 1.2 billion), even as the total revenue, including the domestic figures, stood at Rs 8,541 crore (Rs 85.41 billion).

Now, a 4-in-1 vaccine from Shanta Biotech

Now, a 4-in-1 vaccine from Shanta Biotech

Rediff.com19 Aug 2005

Shantha Biotechnics Ltd on Friday announced the availability of 'Shantetra', a combination vaccine against diphtheria, tetanus, pertussis and hepatitis-B, claimed to be the first indigenously developed four-in-one immunity shot.

Why WHO suspended supply of Covaxin through UN agencies

Why WHO suspended supply of Covaxin through UN agencies

Rediff.com4 Apr 2022

Sources close to the development said the company had no further supply commitments to the WHO, and therefore, there was no suspension of any upcoming orders, reports Sohini Das.

BJP, Cong spar over syrup related deaths in Uzbekistan, Gambia

BJP, Cong spar over syrup related deaths in Uzbekistan, Gambia

Rediff.com29 Dec 2022

While the opposition party asked the government to stop boasting about India being a pharmacy to the world and take strictest action, the ruling party accused it of deriding India in its "hate" for Prime Minister Narendra Modi.

Bharat Bio's nasal Covid vaccine gets regulator nod for phase 3 trials

Bharat Bio's nasal Covid vaccine gets regulator nod for phase 3 trials

Rediff.com28 Jan 2022

India's drug regulator has given permission to Bharat Biotech to conduct phase-3 clinical trial for its intranasal Covid vaccine as booster dose on participants who have been previously inoculated with SARS-CoV 2 vaccines.

Explained: What the Brazil-Covaxin row is about

Explained: What the Brazil-Covaxin row is about

Rediff.com9 Jul 2021

Three entities are at the centre of this controversy: The Brazilian government, Bharat Biotech and a Singapore-based company called Madison Biotech.

Domestic MFs anchoring more listings as issue sizes shrink

Domestic MFs anchoring more listings as issue sizes shrink

Rediff.com27 Sep 2023

Domestic mutual funds (MFs) have underpinned demand for most public floats this year, dominated by small- and mid-sized initial public offerings (IPOs). Of the 24 IPOs that have hit the market so far this financial year (2023-24, or FY24), MFs have played the role of 'anchor investors' in 20. They have subscribed to over 40 per cent, or Rs 2,850 crore, worth of shares of the Rs 6,900 crore on offer in the anchor category, according to data provided by PRIME Database, a firm that tracks primary market data.

Sterling Biotech year net at Rs 21.62 cr

Sterling Biotech year net at Rs 21.62 cr

Rediff.com26 Feb 2003

Sterling Biotech Ltd has posted a net profit of Rs 216.29 million for the year ended December 31, 2002 as compared to a net profit of Rs 203.21 million for the year ended December 31, 2001.

'ChatGPT' Vivek Ramaswamy in 2nd spot behind Trump after US debate

'ChatGPT' Vivek Ramaswamy in 2nd spot behind Trump after US debate

Rediff.com24 Aug 2023

Former New Jersey Governor Chris Christie and a Republican presidential aspirant have called his fellow rival Indian-American Vivek Ramaswamy a guy who sounds like ChatGPT and described him as an "amateur" Barack Obama.

'None of the existing vaccines can prevent emerging variants of Omicron'

'None of the existing vaccines can prevent emerging variants of Omicron'

Rediff.com25 Jan 2023

'We seem to be in a situation where we can do little, and nothing needs to be done anyway.'

US can declare 'independence' from China with India's help: Vivek Ramaswamy

US can declare 'independence' from China with India's help: Vivek Ramaswamy

Rediff.com27 Aug 2023

He is currently on a two-day swing to the crucial State of Iowa. On January 15, Iowa would kick off the 2024 Republican presidential primary season.

Sterling Biotech Q3 net at Rs 39 lakh

Sterling Biotech Q3 net at Rs 39 lakh

Rediff.com13 Jan 2003

Sterling Biotech Q3 net at Rs 39 lakh

3 Indian biotech firms to set up labs in Germany

3 Indian biotech firms to set up labs in Germany

Rediff.com23 Aug 2004

Three Indian biotech firms have plans to set up research and development centres at the Frankfurt Innovation Centre for Biotechnology.

WHO suspends Covaxin supply to UN agencies

WHO suspends Covaxin supply to UN agencies

Rediff.com3 Apr 2022

A statement issued by the WHO on Saturday said the suspension is in response to the outcomes of its post EUL (emergency use authorisation) inspection held between March 14-22, 2022 and the need to conduct process and facility upgrade to address recently identified GMP (good manufacturing practice) deficiencies.

Padma Bhushan for Indian vaccine makers

Padma Bhushan for Indian vaccine makers

Rediff.com25 Jan 2022

Microsoft Chairman and CEO Satya Nadella along with Alphabet Inc and its subsidiary Google CEO Sundararajan Pichai are also among those from trade and industry who have been awarded the Padma Bhushan for their distinguished services.